---
document_datetime: 2023-09-21 17:48:41
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ipreziv-epar-all-authorised-presentations_en.pdf
document_name: ipreziv-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.030769
conversion_datetime: 2025-12-29 23:18:16.378887
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EMEA Number     | (Invented) name   | Strength        | Pharmaceutical Form   | Route of Administration authorised   | Packaging         | Package size   |
|-----------------|-------------------|-----------------|-----------------------|--------------------------------------|-------------------|----------------|
| EU/1/11/735/001 | Ipreziv           | 20 mg           | Tablet                | Oral use                             | blister (alu/alu) | 14 tablets     |
| EU/1/11/735/002 | Ipreziv           | 20 mg           | Tablet                | Oral use                             | blister (alu/alu) | 28 tablets     |
| EU/1/11/735/003 | Ipreziv           | 20 mg           | Tablet                | Oral use                             | blister (alu/alu) | 56 tablets     |
| EU/1/11/735/004 | Ipreziv           | 20 mg           | Tablet                | Oral use                             | blister (alu/alu) | 98 tablets     |
| EU/1/11/735/005 | Ipreziv           | 40 mg           | Tablet                | Oral use                             | blister (alu/alu) | 14 tablets     |
| EU/1/11/735/006 | Ipreziv           | 40 mg           | Tablet                | Oral use                             | blister (alu/alu) | 28 tablets     |
| EU/1/11/735/007 | Ipreziv           | 40 mg           | Tablet                | Oral use                             | blister (alu/alu) | 56 tablets     |
| EU/1/11/735/008 | Ipreziv           | 40 mg           | Tablet                | Oral use longer                      | blister (alu/alu) | 98 tablets     |
| EU/1/11/735/009 | Ipreziv           | 80 mg           | Tablet                | Oral use                             | blister (alu/alu) | 28 tablets     |
| EU/1/11/735/010 | Ipreziv           | 80 mg           | Tablet no             | Oral use                             | blister (alu/alu) | 56 tablets     |
| EU/1/11/735/011 | Ipreziv           | 80 mg           | Tablet                | Oral use                             | blister (alu/alu) | 98 tablets     |
| EU/1/11/735/012 | Ipreziv           | 20 mg           | Tablet                | Oral use                             | blister (alu/alu) | 30 tablets     |
| EU/1/11/735/013 | Ipreziv           | 20 mg           | Tablet                | Oral use                             | blister (alu/alu) | 90 tablets     |
| EU/1/11/735/014 | Ipreziv           | 40 mg           | Tablet product        | Oral use                             | blister (alu/alu) | 30 tablets     |
| EU/1/11/735/015 | Ipreziv           | 40 mg           | Tablet                | Oral use                             | blister (alu/alu) | 90 tablets     |
| EU/1/11/735/016 | Ipreziv           | 80 mg Medicinal | Tablet                | Oral use                             | blister (alu/alu) | 14 tablets     |
| EU/1/11/735/017 | Ipreziv           | 80 mg           | Tablet                | Oral use                             | blister (alu/alu) | 30 tablets     |
| EU/1/11/735/018 | Ipreziv           | 80 mg           | Tablet                | Oral use                             | blister (alu/alu) | 90 tablets     |